Research Tracker›Biomarker Atlas›Marker Pages›Anti-idiotype antibodies (ACE2 ↔ Anti-S)

Anti-idiotype antibodies (ACE2 ↔ Anti-S): biomarker evidence

Anti-idiotype antibodies (ACE2 ↔ Anti-S) appears in 1 entry of the OSMF biomarker atlas, covering PACVS. Across those entries it is mixed in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

PACVS

Where Anti-idiotype antibodies (ACE2 ↔ Anti-S) is reported

Also listed as: Immunopathogenic mechanism

ConditionDirectionCompared againstAssociated symptomsSource
PACVS↕ inconsistentInternal correlationACE2 levels correlate with anti-S titersMantovani et al. 2024

Frequently asked questions

In which conditions is Anti-idiotype antibodies (ACE2 ↔ Anti-S) altered?

In the OSMF atlas Anti-idiotype antibodies (ACE2 ↔ Anti-S) is reported in PACVS. It is mixed in 1 across 1 entries.

Is there a standard clinical test for Anti-idiotype antibodies (ACE2 ↔ Anti-S)?

The atlas entries for Anti-idiotype antibodies (ACE2 ↔ Anti-S) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Anti-idiotype antibodies (ACE2 ↔ Anti-S) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Anti-idiotype antibodies (ACE2 ↔ Anti-S) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/anti-idiotype-antibodies-ace2-anti-s.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.